Log In
Print this Print this

Desmoteplase (DPSA)

  Manage Alerts
Collapse Summary General Information
Company H. Lundbeck A/S
DescriptionGenetically engineered fibrin-dependent salivary plasminogen activator from the vampire bat Desmodus rotundus
Molecular Target Plasminogen
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase III
Standard IndicationStroke
Indication DetailsTreat acute ischemic stroke; Treat hemorrhagic stroke; Treat stroke
Regulatory Designation
Partner Bayer AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today